nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absorption-promoting adjuvants: enhancing action on rectal absorption
|
Nishihata, Toshiaki |
|
1997 |
69-70 |
2 |
p. 205-228 24 p. |
artikel |
2 |
A case for prodrugs: Fosphenytoin
|
Stella, Valentino J. |
|
1996 |
69-70 |
2 |
p. 311-330 20 p. |
artikel |
3 |
Advancements in immune tolerance
|
Pan, Ping-Ying |
|
2008 |
69-70 |
2 |
p. 91-105 15 p. |
artikel |
4 |
Advances in targeted delivery
|
Pouton, Colin W |
|
2001 |
69-70 |
2 |
p. 133-134 2 p. |
artikel |
5 |
Amperometric enzyme biosensors for the analysis of drugs and metabolites
|
Harwood, G.W.John |
|
1996 |
69-70 |
2 |
p. 163-191 29 p. |
artikel |
6 |
Announcement
|
|
|
1989 |
69-70 |
2 |
p. 277- 1 p. |
artikel |
7 |
Announcement from the publishers
|
|
|
1991 |
69-70 |
2 |
p. iii- 1 p. |
artikel |
8 |
Antibody structure and antibody engineering
|
Tan, Lee K. |
|
1988 |
69-70 |
2 |
p. 129-142 14 p. |
artikel |
9 |
Antisense oligonucleotide therapeutics: drug delivery and targeting
|
Rojanasakul, Yongyut |
|
1996 |
69-70 |
2 |
p. 115-131 17 p. |
artikel |
10 |
Antisense strategies in degenerative joint diseases: Sense or nonsense?
|
Huber, Lars C. |
|
2006 |
69-70 |
2 |
p. 285-299 15 p. |
artikel |
11 |
Application of numerical methods for diffusion-based modeling of skin permeation
|
Frasch, H. Frederick |
|
2013 |
69-70 |
2 |
p. 208-220 13 p. |
artikel |
12 |
Are there predictors of Remicade treatment success or failure?
|
Su, Chinyu |
|
2005 |
69-70 |
2 |
p. 237-245 9 p. |
artikel |
13 |
Arginine containing peptides as delivery vectors
|
Tung, Ching-Hsuan |
|
2003 |
69-70 |
2 |
p. 281-294 14 p. |
artikel |
14 |
ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects
|
Park, Yoon-Jeong |
|
2003 |
69-70 |
2 |
p. 251-265 15 p. |
artikel |
15 |
Bacterial pore-forming hemolysins and their use in the cytosolic delivery of macromolecules
|
Provoda, Chester J |
|
2000 |
69-70 |
2 |
p. 209-221 13 p. |
artikel |
16 |
Barrier properties of mucus
|
Cone, Richard A. |
|
2009 |
69-70 |
2 |
p. 75-85 11 p. |
artikel |
17 |
Beta-cell replacement for insulin-dependent diabetes mellitus
|
Efrat, Shimon |
|
2008 |
69-70 |
2 |
p. 114-123 10 p. |
artikel |
18 |
Beyond oncology — Application of HPMA copolymers in non-cancerous diseases
|
Liu, Xin-Ming |
|
2010 |
69-70 |
2 |
p. 258-271 14 p. |
artikel |
19 |
Biocompatibility of biomaterials: hemocompatibility, immunocompatiblity and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers
|
Říhová, Blanka |
|
1996 |
69-70 |
2 |
p. 157-176 20 p. |
artikel |
20 |
Bioconjugates for effective drug targeting
|
|
|
2003 |
69-70 |
2 |
p. 169-170 2 p. |
artikel |
21 |
Biodegradable soluble macromolecules as drug carriers
|
Drobník, Jaroslav |
|
1989 |
69-70 |
2 |
p. 229-245 17 p. |
artikel |
22 |
Biologics in development for rheumatoid arthritis: Relevance to osteoarthritis
|
Abramson, Steven B. |
|
2006 |
69-70 |
2 |
p. 212-225 14 p. |
artikel |
23 |
Biomaterials for stem cell differentiation
|
Dawson, Eileen |
|
2008 |
69-70 |
2 |
p. 215-228 14 p. |
artikel |
24 |
Biomimetic materials for tissue engineering
|
Ma, Peter X. |
|
2008 |
69-70 |
2 |
p. 184-198 15 p. |
artikel |
25 |
Bioreductive and gene therapy approaches to hypoxic diseases
|
Jaffar, Mohammed |
|
2001 |
69-70 |
2 |
p. 217-228 12 p. |
artikel |
26 |
Biosensing and drug delivery at the microscale
|
Siegel, Ronald A. |
|
2004 |
69-70 |
2 |
p. 121-123 3 p. |
artikel |
27 |
Biosynthetic polyhydroxyalkanoates and their potential in drug delivery
|
Pouton, Colin W. |
|
1996 |
69-70 |
2 |
p. 133-162 30 p. |
artikel |
28 |
Bispecific antibody conjugates in therapeutics
|
Cao, Ying |
|
2003 |
69-70 |
2 |
p. 171-197 27 p. |
artikel |
29 |
Block copolymer micelles as drug delivery systems
|
|
|
2002 |
69-70 |
2 |
p. 167- 1 p. |
artikel |
30 |
Block copolymer micelles for delivery of gene and related compounds
|
Kakizawa, Yoshinori |
|
2002 |
69-70 |
2 |
p. 203-222 20 p. |
artikel |
31 |
Breaching the skin barrier — Insights from molecular simulation of model membranes
|
Notman, Rebecca |
|
2013 |
69-70 |
2 |
p. 237-250 14 p. |
artikel |
32 |
Cartilage tissue engineering for degenerative joint disease
|
Nesic, Dobrila |
|
2006 |
69-70 |
2 |
p. 300-322 23 p. |
artikel |
33 |
Catabolism of therapeutic proteins and peptides with implications for drug delivery
|
Bocci, Velio |
|
1989 |
69-70 |
2 |
p. 149-169 21 p. |
artikel |
34 |
Cell-based drug delivery
|
Pierigè, F. |
|
2008 |
69-70 |
2 |
p. 286-295 10 p. |
artikel |
35 |
Cell sheet engineering for heart tissue repair
|
Masuda, Shinako |
|
2008 |
69-70 |
2 |
p. 277-285 9 p. |
artikel |
36 |
Cell therapy for spinal cord regeneration
|
Willerth, Stephanie M. |
|
2008 |
69-70 |
2 |
p. 263-276 14 p. |
artikel |
37 |
Cellular and biochemical interactions of macromolecular drug delivery systems
|
Artursson, Per |
|
1989 |
69-70 |
2 |
p. 165-189 25 p. |
artikel |
38 |
Cellular delivery of peptide nucleic acid (PNA)
|
Koppelhus, Uffe |
|
2003 |
69-70 |
2 |
p. 267-280 14 p. |
artikel |
39 |
Cellular events in the uptake and degradation of hyaluronan
|
Smedsrød, Bård |
|
1991 |
69-70 |
2 |
p. 265-278 14 p. |
artikel |
40 |
Challenges and emerging technologies in the immunoisolation of cells and tissues
|
Wilson, John T. |
|
2008 |
69-70 |
2 |
p. 124-145 22 p. |
artikel |
41 |
Chemically modified chitosans as enzyme inhibitors
|
Bernkop-Schnürch, Andreas |
|
2001 |
69-70 |
2 |
p. 127-137 11 p. |
artikel |
42 |
Chitosan for mucosal vaccination
|
van der Lubben, I.M |
|
2001 |
69-70 |
2 |
p. 139-144 6 p. |
artikel |
43 |
Chitosans for gene delivery
|
Borchard, Gerrit |
|
2001 |
69-70 |
2 |
p. 145-150 6 p. |
artikel |
44 |
Clearance of hyaluronan from the circulation
|
Lebel, Lena |
|
1991 |
69-70 |
2 |
p. 221-235 15 p. |
artikel |
45 |
Closed-loop insulin delivery—the path to physiological glucose control
|
Steil, G.M |
|
2004 |
69-70 |
2 |
p. 125-144 20 p. |
artikel |
46 |
Conditional gene targeting for cancer gene therapy
|
Haviv, Yosef S. |
|
2001 |
69-70 |
2 |
p. 135-154 20 p. |
artikel |
47 |
Controlled differentiation of stem cells
|
Hwang, Nathaniel S. |
|
2008 |
69-70 |
2 |
p. 199-214 16 p. |
artikel |
48 |
Controlled drug delivery in tissue engineering
|
Biondi, Marco |
|
2008 |
69-70 |
2 |
p. 229-242 14 p. |
artikel |
49 |
Critical appraisal of the in vitro immunization technology for the production of mouse and human monoclonal antibodies
|
Borrebaeck, Carl A.K. |
|
1988 |
69-70 |
2 |
p. 143-165 23 p. |
artikel |
50 |
Cyclodextrins in oligonucleotide delivery
|
Redenti, Enrico |
|
2001 |
69-70 |
2 |
p. 235-244 10 p. |
artikel |
51 |
Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells
|
Rao, Mangala |
|
2000 |
69-70 |
2 |
p. 171-188 18 p. |
artikel |
52 |
Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure
|
Dancik, Yuri |
|
2013 |
69-70 |
2 |
p. 221-236 16 p. |
artikel |
53 |
Detailed modeling of skin penetration—An overview
|
Naegel, Arne |
|
2013 |
69-70 |
2 |
p. 191-207 17 p. |
artikel |
54 |
Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities
|
Duncan, Ruth |
|
2010 |
69-70 |
2 |
p. 272-282 11 p. |
artikel |
55 |
Drug and gene delivery to mucosal tissues: the mucus barrier
|
Hanes, Justin |
|
2009 |
69-70 |
2 |
p. 73-74 2 p. |
artikel |
56 |
Drug delivery in advancing the treatment of inflammatory bowel disease
|
|
|
2005 |
69-70 |
2 |
p. 215-216 2 p. |
artikel |
57 |
Drug delivery in degenerative joint disease
|
Aigner, Thomas |
|
2006 |
69-70 |
2 |
p. 123-124 2 p. |
artikel |
58 |
Drug delivery in degenerative joint disease: Where we are and where to go?
|
Abramson, Steven |
|
2006 |
69-70 |
2 |
p. 125-127 3 p. |
artikel |
59 |
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities
|
Saito, Go |
|
2003 |
69-70 |
2 |
p. 199-215 17 p. |
artikel |
60 |
Drug delivery systems using hyaluronan and its derivatives
|
Larsen, Nancy E. |
|
1991 |
69-70 |
2 |
p. 279-293 15 p. |
artikel |
61 |
Drug delivery to mitochondria: the key to mitochondrial medicine
|
Murphy, Michael P |
|
2000 |
69-70 |
2 |
p. 235-250 16 p. |
artikel |
62 |
Drug targeting to hypoxic tissue using self-inactivating bioreductive delivery systems
|
Naughton, D.P |
|
2001 |
69-70 |
2 |
p. 229-233 5 p. |
artikel |
63 |
Editorial
|
Lévy, Raphaël |
|
2012 |
69-70 |
2 |
p. 127-128 2 p. |
artikel |
64 |
Editorial Board
|
|
|
2009 |
69-70 |
2 |
p. ii- 1 p. |
artikel |
65 |
Editorial Board
|
|
|
2010 |
69-70 |
2 |
p. ii- 1 p. |
artikel |
66 |
Editorial Board
|
|
|
2013 |
69-70 |
2 |
p. ii- 1 p. |
artikel |
67 |
Editorial Board
|
|
|
2003 |
69-70 |
2 |
p. ii- 1 p. |
artikel |
68 |
Editorial Board
|
|
|
2006 |
69-70 |
2 |
p. ii- 1 p. |
artikel |
69 |
Editorial Board
|
|
|
2004 |
69-70 |
2 |
p. ii- 1 p. |
artikel |
70 |
Editorial Board
|
|
|
2008 |
69-70 |
2 |
p. ii- 1 p. |
artikel |
71 |
Editorial Board
|
|
|
2005 |
69-70 |
2 |
p. ii- 1 p. |
artikel |
72 |
Editorial Board
|
|
|
2012 |
69-70 |
2 |
p. ii- 1 p. |
artikel |
73 |
Effective drug delivery by PEGylated drug conjugates
|
Greenwald, Richard B. |
|
2003 |
69-70 |
2 |
p. 217-250 34 p. |
artikel |
74 |
Electronic MEMS for triggered delivery
|
Richards Grayson, Amy C. |
|
2004 |
69-70 |
2 |
p. 173-184 12 p. |
artikel |
75 |
Emerging trends in cell-based therapies
|
Ye, Zhaoyang |
|
2008 |
69-70 |
2 |
p. 89-90 2 p. |
artikel |
76 |
Endosomes, lysosomes: their implication in gene transfer
|
Wattiaux, Robert |
|
2000 |
69-70 |
2 |
p. 201-208 8 p. |
artikel |
77 |
Endothelial cell biology and culture methods for drug transport studies
|
Angelis, Elena De |
|
1996 |
69-70 |
2 |
p. 193-218 26 p. |
artikel |
78 |
Engineering cartilage tissue
|
Chung, Cindy |
|
2008 |
69-70 |
2 |
p. 243-262 20 p. |
artikel |
79 |
Enzyme immobilization in liquid surfactant membrane emulsions
|
Scheper, Thomas |
|
1989 |
69-70 |
2 |
p. 209-231 23 p. |
artikel |
80 |
Erratum
|
|
|
1991 |
69-70 |
2 |
p. 311- 1 p. |
artikel |
81 |
Extracellular barriers in respiratory gene therapy
|
Sanders, Niek |
|
2009 |
69-70 |
2 |
p. 115-127 13 p. |
artikel |
82 |
Ex vivo gene therapy approaches to cartilage repair
|
Gelse, K. |
|
2006 |
69-70 |
2 |
p. 259-284 26 p. |
artikel |
83 |
Finite and infinite dosing: Difficulties in measurements, evaluations and predictions
|
Selzer, Dominik |
|
2013 |
69-70 |
2 |
p. 278-294 17 p. |
artikel |
84 |
Flow control with hydrogels
|
Eddington, David T. |
|
2004 |
69-70 |
2 |
p. 199-210 12 p. |
artikel |
85 |
Forthcoming event
|
|
|
1991 |
69-70 |
2 |
p. 234- 1 p. |
artikel |
86 |
Forthcoming events
|
|
|
1996 |
69-70 |
2 |
p. 269-270 2 p. |
artikel |
87 |
Forthcoming Events
|
|
|
1991 |
69-70 |
2 |
p. 309-310 2 p. |
artikel |
88 |
Forthcoming events
|
|
|
1995 |
69-70 |
2 |
p. 205-206 2 p. |
artikel |
89 |
Gene therapeutic approaches—transfer in vivo
|
Evans, C.H. |
|
2006 |
69-70 |
2 |
p. 243-258 16 p. |
artikel |
90 |
Genetic modification of cells for transplantation
|
Lai, Yi |
|
2008 |
69-70 |
2 |
p. 146-159 14 p. |
artikel |
91 |
Genetic modification of stem cells for transplantation
|
Phillips, M. Ian |
|
2008 |
69-70 |
2 |
p. 160-172 13 p. |
artikel |
92 |
Gene transfection and lymphocyte immortalization: a new approach to human monoclonal antibody production
|
Jonak, Z.L. |
|
1988 |
69-70 |
2 |
p. 207-228 22 p. |
artikel |
93 |
Gene-transfer systems for human endothelial cells
|
Martin, S.G |
|
2000 |
69-70 |
2 |
p. 223-233 11 p. |
artikel |
94 |
Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy
|
Griesenbach, Uta |
|
2009 |
69-70 |
2 |
p. 128-139 12 p. |
artikel |
95 |
Gold nanorods: Their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions
|
Alkilany, Alaaldin M. |
|
2012 |
69-70 |
2 |
p. 190-199 10 p. |
artikel |
96 |
Guide to Authors
|
|
|
2004 |
69-70 |
2 |
p. 231-234 4 p. |
artikel |
97 |
Guide to Authors
|
|
|
2005 |
69-70 |
2 |
p. 317-320 4 p. |
artikel |
98 |
Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery
|
Ziaie, Babak |
|
2004 |
69-70 |
2 |
p. 145-172 28 p. |
artikel |
99 |
Hepatic first-pass effect and controlled drug delivery following rectal administration
|
de Boer, A.G. |
|
1997 |
69-70 |
2 |
p. 229-237 9 p. |
artikel |
100 |
Hormone containing growth promoting implants in farmed livestock
|
Preston, R.L. |
|
1999 |
69-70 |
2 |
p. 123-138 16 p. |
artikel |
101 |
HPMA copolymer–cyclic RGD conjugates for tumor targeting
|
Pike, Daniel B. |
|
2010 |
69-70 |
2 |
p. 167-183 17 p. |
artikel |
102 |
HPMA copolymers for masking and retargeting of therapeutic viruses
|
Fisher, Kerry D. |
|
2010 |
69-70 |
2 |
p. 240-245 6 p. |
artikel |
103 |
HPMA copolymers for modulating cellular signaling and overcoming multidrug resistance
|
Minko, Tamara |
|
2010 |
69-70 |
2 |
p. 192-202 11 p. |
artikel |
104 |
HPMA copolymers: Origins, early developments, present, and future
|
Kopeček, Jindřich |
|
2010 |
69-70 |
2 |
p. 122-149 28 p. |
artikel |
105 |
HPMA copolymers: 30years of advances
|
Lammers, Twan |
|
2010 |
69-70 |
2 |
p. 119-121 3 p. |
artikel |
106 |
Hyaluronan-binding proteins and receptors
|
Turley, Eva A. |
|
1991 |
69-70 |
2 |
p. 257-264 8 p. |
artikel |
107 |
Hyaluronan in drug delivery
|
Drobnik, Jaroslav |
|
1991 |
69-70 |
2 |
p. 295-308 14 p. |
artikel |
108 |
Immunogenicity and immunomodulatory properties of HPMA-based polymers
|
Říhová, Blanka |
|
2010 |
69-70 |
2 |
p. 184-191 8 p. |
artikel |
109 |
Immunotherapy with dendritic cells for cancer
|
Ballestrero, Alberto |
|
2008 |
69-70 |
2 |
p. 173-183 11 p. |
artikel |
110 |
Improved input parameters for diffusion models of skin absorption
|
Hansen, Steffi |
|
2013 |
69-70 |
2 |
p. 251-264 14 p. |
artikel |
111 |
Improved oral drug delivery: solubility limitations overcome by the use of prodrugs
|
Fleisher, David |
|
1996 |
69-70 |
2 |
p. 115-130 16 p. |
artikel |
112 |
Improved passive oral drug delivery via prodrugs
|
Taylor, Michael D. |
|
1996 |
69-70 |
2 |
p. 131-148 18 p. |
artikel |
113 |
Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations
|
Lammers, Twan |
|
2010 |
69-70 |
2 |
p. 203-230 28 p. |
artikel |
114 |
Induction of immune tolerance to facilitate β cell regeneration in type 1 diabetes
|
Pasquali, Lorenzo |
|
2008 |
69-70 |
2 |
p. 106-113 8 p. |
artikel |
115 |
Integrated microsystems for controlled drug delivery
|
Zafar Razzacki, S. |
|
2004 |
69-70 |
2 |
p. 185-198 14 p. |
artikel |
116 |
Intraarticular drug delivery in osteoarthritis
|
Gerwin, Nicole |
|
2006 |
69-70 |
2 |
p. 226-242 17 p. |
artikel |
117 |
Intrauterine administration of peptide drugs for systemic effect
|
Golomb, G. |
|
1995 |
69-70 |
2 |
p. 179-190 12 p. |
artikel |
118 |
Intrauterine contraceptive device — status report
|
Chi, I-cheng |
|
1995 |
69-70 |
2 |
p. 165-178 14 p. |
artikel |
119 |
Key issues in the purification and characterization of recombinant proteins for therapeutic use
|
Sharma, Satish K. |
|
1989 |
69-70 |
2 |
p. 87-111 25 p. |
artikel |
120 |
Lessons from nature: “Pathogen-Mimetic” systems for mucosal Nano-medicines
|
Mrsny, Randall J. |
|
2009 |
69-70 |
2 |
p. 172-192 21 p. |
artikel |
121 |
Lipophilic prodrugs designed for intestinal lymphatic transport
|
Charman, William N. |
|
1996 |
69-70 |
2 |
p. 149-169 21 p. |
artikel |
122 |
Long-acting control of ectoparasites: a review of collar technologies for companion animals
|
Witchey-Lakshmanan, Leonore C |
|
1999 |
69-70 |
2 |
p. 113-122 10 p. |
artikel |
123 |
Luminescent quantum dots as platforms for probing in vitro and in vivo biological processes
|
Mattoussi, Hedi |
|
2012 |
69-70 |
2 |
p. 138-166 29 p. |
artikel |
124 |
Lymphatic delivery in ‘rectal drug delivery systems’
|
Yoshikawa, Hiroshi |
|
1997 |
69-70 |
2 |
p. 239-251 13 p. |
artikel |
125 |
Lysosome membrane permeability: implications for drug delivery
|
Lloyd, John B |
|
2000 |
69-70 |
2 |
p. 189-200 12 p. |
artikel |
126 |
Macromolecular systems for chemotherapy and magnetic resonance imaging
|
Matthews, Susan E. |
|
1996 |
69-70 |
2 |
p. 219-267 49 p. |
artikel |
127 |
Mathematical and pharmacokinetic modelling of epidermal and dermal transport processes
|
Anissimov, Yuri G. |
|
2013 |
69-70 |
2 |
p. 169-190 22 p. |
artikel |
128 |
Mathematical modeling of molecular diffusion through mucus
|
Cu, Yen |
|
2009 |
69-70 |
2 |
p. 101-114 14 p. |
artikel |
129 |
Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier
|
Gratieri, Taís |
|
2013 |
69-70 |
2 |
p. 315-329 15 p. |
artikel |
130 |
Mesalamine delivery systems: do they really make much difference?
|
Qureshi, Altamash I. |
|
2005 |
69-70 |
2 |
p. 281-302 22 p. |
artikel |
131 |
Micelles based on HPMA copolymers
|
Talelli, M. |
|
2010 |
69-70 |
2 |
p. 231-239 9 p. |
artikel |
132 |
Micro- and macrorheology of mucus
|
Lai, Samuel K. |
|
2009 |
69-70 |
2 |
p. 86-100 15 p. |
artikel |
133 |
Micromachined biocapsules for cell-based sensing and delivery
|
Leoni, Lara |
|
2004 |
69-70 |
2 |
p. 211-229 19 p. |
artikel |
134 |
Modeling the human skin barrier — Towards a better understanding of dermal absorption
|
Jepps, Owen G. |
|
2013 |
69-70 |
2 |
p. 152-168 17 p. |
artikel |
135 |
Modeling the human skin barrier—Towards a better understanding of dermal absorption
|
Hansen, Steffi |
|
2013 |
69-70 |
2 |
p. 149-151 3 p. |
artikel |
136 |
Modern drug delivery applications of chitosan
|
|
|
2001 |
69-70 |
2 |
p. 103- 1 p. |
artikel |
137 |
Molecular imaging of HPMA copolymers: Visualizing drug delivery in cell, mouse and man
|
Lu, Zheng-Rong |
|
2010 |
69-70 |
2 |
p. 246-257 12 p. |
artikel |
138 |
Monolayer coated gold nanoparticles for delivery applications
|
Rana, Subinoy |
|
2012 |
69-70 |
2 |
p. 200-216 17 p. |
artikel |
139 |
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
|
Lai, Samuel K. |
|
2009 |
69-70 |
2 |
p. 158-171 14 p. |
artikel |
140 |
Nanoparticles for nasal vaccination
|
Csaba, Noemi |
|
2009 |
69-70 |
2 |
p. 140-157 18 p. |
artikel |
141 |
New adjuvants for vaccines containing purified protein antigens
|
Eppstein, Deborah A. |
|
1989 |
69-70 |
2 |
p. 233-253 21 p. |
artikel |
142 |
New biologically active fragments of immunoglobulins
|
Chipens, Gunar |
|
1988 |
69-70 |
2 |
p. 167-206 40 p. |
artikel |
143 |
New oral delivery systems for treatment of inflammatory bowel disease
|
Friend, David R. |
|
2005 |
69-70 |
2 |
p. 247-265 19 p. |
artikel |
144 |
NLS bioconjugates for targeting therapeutic genes to the nucleus
|
Escriou, Virginie |
|
2003 |
69-70 |
2 |
p. 295-306 12 p. |
artikel |
145 |
Oral drug absorption enhancement by chitosan and its derivatives
|
Thanou, M |
|
2001 |
69-70 |
2 |
p. 117-126 10 p. |
artikel |
146 |
Oral treatment options for degenerative joint disease—presence and future
|
Steinmeyer, Jürgen |
|
2006 |
69-70 |
2 |
p. 168-211 44 p. |
artikel |
147 |
Osmotic delivery of peptides and macromolecules
|
Amkraut, A. |
|
1989 |
69-70 |
2 |
p. 255-276 22 p. |
artikel |
148 |
Osteoarthritis
|
Buckwalter, Joseph A. |
|
2006 |
69-70 |
2 |
p. 150-167 18 p. |
artikel |
149 |
Osteoarthritis: Pathobiology—targets and ways for therapeutic intervention
|
Aigner, T. |
|
2006 |
69-70 |
2 |
p. 128-149 22 p. |
artikel |
150 |
Pathophysiology and treatment of pain in joint disease
|
Schaible, Hans-Georg |
|
2006 |
69-70 |
2 |
p. 323-342 20 p. |
artikel |
151 |
PEG-based micelles as carriers of contrast agents for different imaging modalities
|
Torchilin, Vladimir P |
|
2002 |
69-70 |
2 |
p. 235-252 18 p. |
artikel |
152 |
Penetration and enzymatic barriers to peptide and protein absorption
|
Lee, Vincent H.L. |
|
1989 |
69-70 |
2 |
p. 171-207 37 p. |
artikel |
153 |
Peptide drug delivery: Colonic and rectal absorption
|
Mackay, Martin |
|
1997 |
69-70 |
2 |
p. 253-273 21 p. |
artikel |
154 |
Pharmacokinetic and pharmacodynamic aspects of site-specific drug delivery
|
Boddy, Alan |
|
1989 |
69-70 |
2 |
p. 155-163 9 p. |
artikel |
155 |
Pharmacokinetic evaluation of polymeric carriers
|
Nishikawa, Makiya |
|
1996 |
69-70 |
2 |
p. 135-155 21 p. |
artikel |
156 |
Pharmacokinetics and pharmacodynamics of trans-endometrial administered peptides and macromolecules
|
Huffman, A. |
|
1995 |
69-70 |
2 |
p. 191-203 13 p. |
artikel |
157 |
Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution
|
Dufort, Sandrine |
|
2012 |
69-70 |
2 |
p. 179-189 11 p. |
artikel |
158 |
Physiology of the colorectal barrier
|
Edwards, Christine |
|
1997 |
69-70 |
2 |
p. 173-190 18 p. |
artikel |
159 |
Pluronic® block copolymers: novel functional molecules for gene therapy
|
Kabanov, Alexander V |
|
2002 |
69-70 |
2 |
p. 223-233 11 p. |
artikel |
160 |
Polyether–polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations
|
Liggins, R.T. |
|
2002 |
69-70 |
2 |
p. 191-202 12 p. |
artikel |
161 |
Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery
|
Lavasanifar, Afsaneh |
|
2002 |
69-70 |
2 |
p. 169-190 22 p. |
artikel |
162 |
Polymeric micelles as new drug carriers
|
Kwon, Glen S. |
|
1996 |
69-70 |
2 |
p. 107-116 10 p. |
artikel |
163 |
Polymer-modified proteins: preclinical development and regulatory strategies
|
Hoyle, Peter C. |
|
1991 |
69-70 |
2 |
p. 219-233 15 p. |
artikel |
164 |
Predicting skin permeability from complex vehicles
|
Karadzovska, Daniela |
|
2013 |
69-70 |
2 |
p. 265-277 13 p. |
artikel |
165 |
Predicting the absorption of chemical vapours
|
Rauma, Matias |
|
2013 |
69-70 |
2 |
p. 306-314 9 p. |
artikel |
166 |
Preface
|
Golomb, G. |
|
1995 |
69-70 |
2 |
p. 149-150 2 p. |
artikel |
167 |
Preface
|
Muranishi, Shozo |
|
1997 |
69-70 |
2 |
p. 171- 1 p. |
artikel |
168 |
Preface
|
Stella, Valentino J. |
|
1996 |
69-70 |
2 |
p. 111-114 4 p. |
artikel |
169 |
Preface
|
Rathbone, Michael J |
|
1999 |
69-70 |
2 |
p. 111- 1 p. |
artikel |
170 |
Preface
|
Goddard, Peter |
|
1991 |
69-70 |
2 |
p. V-VI nvt p. |
artikel |
171 |
Preface
|
Drobník, J. |
|
1991 |
69-70 |
2 |
p. v- 1 p. |
artikel |
172 |
Preface
|
Tomlinson, Eric |
|
1988 |
69-70 |
2 |
p. iii-iv nvt p. |
artikel |
173 |
Preface
|
Tomlinson, E. |
|
1989 |
69-70 |
2 |
p. iii- 1 p. |
artikel |
174 |
Preface
|
Petrak, K. |
|
1989 |
69-70 |
2 |
p. iii- 1 p. |
artikel |
175 |
Preparation, in vivo properties and proposed clinical use of polyoxyethylene-modified tissue plasminogen activator and streptokinase
|
Pizzo, S.V. |
|
1991 |
69-70 |
2 |
p. 153-166 14 p. |
artikel |
176 |
Prodrugs and targeted drug delivery
|
Kearney, Albert S. |
|
1996 |
69-70 |
2 |
p. 225-239 15 p. |
artikel |
177 |
Prodrugs for improved CNS delivery
|
Anderson, Bradley D. |
|
1996 |
69-70 |
2 |
p. 171-202 32 p. |
artikel |
178 |
Prodrugs for improved ocular drug delivery
|
Järvinen, Tomi |
|
1996 |
69-70 |
2 |
p. 203-224 22 p. |
artikel |
179 |
Prodrugs of anticancer agents
|
Sinhababu, Achintya K. |
|
1996 |
69-70 |
2 |
p. 241-273 33 p. |
artikel |
180 |
Prodrugs of peptides and peptidomimetics for improved formulation and delivery
|
Oliyai, Reza |
|
1996 |
69-70 |
2 |
p. 275-286 12 p. |
artikel |
181 |
Prodrugs of phosphates, phosphonates, and phosphinates
|
Krise, Jeffrey P. |
|
1996 |
69-70 |
2 |
p. 287-310 24 p. |
artikel |
182 |
Properties of asparaginase-dextran conjugates
|
Wileman, Thomas E. |
|
1991 |
69-70 |
2 |
p. 167-180 14 p. |
artikel |
183 |
Pulsatile release from subcutaneous implants
|
Medlicott, Natalie J |
|
1999 |
69-70 |
2 |
p. 139-149 11 p. |
artikel |
184 |
Quantum dots to tail single bio-molecules inside living cells
|
Pierobon, Paolo |
|
2012 |
69-70 |
2 |
p. 167-178 12 p. |
artikel |
185 |
Recent advances in cellular, sub-cellular and molecular targeting
|
Moghimi, S.M |
|
2000 |
69-70 |
2 |
p. 129-133 5 p. |
artikel |
186 |
Recent advances in predicting skin permeability of hydrophilic solutes
|
Chen, Longjian |
|
2013 |
69-70 |
2 |
p. 295-305 11 p. |
artikel |
187 |
Recent advances in the analysis of peptides and proteins by mass spectrometry
|
Carr, Steven A. |
|
1989 |
69-70 |
2 |
p. 113-147 35 p. |
artikel |
188 |
Receptor-mediated targeting of toxins to intraerythrocytic parasite Plasmodium falciparum
|
Surolia, Namita |
|
2000 |
69-70 |
2 |
p. 163-170 8 p. |
artikel |
189 |
Rectal drug delivery systems Improvement of rectal peptide absorption by absorption enhancers, protease inhibitors and chemical modification
|
Yamamoto, Akira |
|
1997 |
69-70 |
2 |
p. 275-299 25 p. |
artikel |
190 |
Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease
|
Siccardi, Dario |
|
2005 |
69-70 |
2 |
p. 219-235 17 p. |
artikel |
191 |
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
|
Maeda, Hiroshi |
|
1991 |
69-70 |
2 |
p. 181-202 22 p. |
artikel |
192 |
Soluble macromolecular carriers for the delivery of antitumour drugs
|
Sezaki, Hitoshi |
|
1989 |
69-70 |
2 |
p. 247-266 20 p. |
artikel |
193 |
Somatotropin delivery to farmed animals
|
Foster, Todd P |
|
1999 |
69-70 |
2 |
p. 151-165 15 p. |
artikel |
194 |
Structural and chemical aspects of HPMA copolymers as drug carriers
|
Ulbrich, Karel |
|
2010 |
69-70 |
2 |
p. 150-166 17 p. |
artikel |
195 |
Suppression of antibody responses by conjugates of antigens and monomethoxypoly(ethylene glycol)
|
Sehon, Alec H. |
|
1991 |
69-70 |
2 |
p. 203-217 15 p. |
artikel |
196 |
Targetable drug carriers: present status and a future perspective
|
Yokoyama, Masayuki |
|
1996 |
69-70 |
2 |
p. 77-80 4 p. |
artikel |
197 |
Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide
|
Fedorak, Richard N. |
|
2005 |
69-70 |
2 |
p. 303-316 14 p. |
artikel |
198 |
Targeted drug conjugates: principles and progress
|
Garnett, Martin C |
|
2001 |
69-70 |
2 |
p. 171-216 46 p. |
artikel |
199 |
Targeted drug delivery via the folate receptor
|
Sudimack, Jennifer |
|
2000 |
69-70 |
2 |
p. 147-162 16 p. |
artikel |
200 |
Targeting gene expression using HSV vectors
|
Burton, Edward A |
|
2001 |
69-70 |
2 |
p. 155-170 16 p. |
artikel |
201 |
The crucial role of spacer groups in macromolecular prodrug design
|
Soyez, Heidi |
|
1996 |
69-70 |
2 |
p. 81-106 26 p. |
artikel |
202 |
Theory and practice of site-specific drug delivery
|
Tomlinson, E. |
|
1987 |
69-70 |
2 |
p. 87-198 112 p. |
artikel |
203 |
Therapeutic opportunities for targeted liposomal drug delivery
|
Allen, Theresa M. |
|
1996 |
69-70 |
2 |
p. 117-133 17 p. |
artikel |
204 |
Therapeutic proteins — a pharmaceutical perspective
|
Goddard, Peter |
|
1991 |
69-70 |
2 |
p. 103-131 29 p. |
artikel |
205 |
The therapeutic value of poly(ethylene glycol)-modified proteins
|
Nucci, Mary L. |
|
1991 |
69-70 |
2 |
p. 133-151 19 p. |
artikel |
206 |
Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease
|
Klotz, Ulrich |
|
2005 |
69-70 |
2 |
p. 267-279 13 p. |
artikel |
207 |
Topical formulations and wound healing applications of chitosan
|
Ueno, Hiroshi |
|
2001 |
69-70 |
2 |
p. 105-115 11 p. |
artikel |
208 |
Toxicology of nanoparticles
|
Elsaesser, Andreas |
|
2012 |
69-70 |
2 |
p. 129-137 9 p. |
artikel |
209 |
Transcellular and paracellular contribution to transport processes in the colorectal route
|
Hayashi, Masahiro |
|
1997 |
69-70 |
2 |
p. 191-204 14 p. |
artikel |
210 |
Transport of macromolecules across the capillary walls
|
Petrak, Karel |
|
1989 |
69-70 |
2 |
p. 191-214 24 p. |
artikel |
211 |
Transport of proteins through the membranes of the adult gastro-intestinal tract — a potential for drug delivery?
|
Pusztai, A. |
|
1989 |
69-70 |
2 |
p. 215-228 14 p. |
artikel |
212 |
Treatment targets in inflammatory bowel disease
|
Sellin, Joseph |
|
2005 |
69-70 |
2 |
p. 217-218 2 p. |
artikel |
213 |
Tuftsin-bearing liposomes in treatment of macrophage-based infections
|
Agrawal, Ajay K |
|
2000 |
69-70 |
2 |
p. 135-146 12 p. |
artikel |
214 |
Turnover of hyaluronan in the tissues
|
Laurent, Ulla B.G. |
|
1991 |
69-70 |
2 |
p. 237-256 20 p. |
artikel |
215 |
Twelfth International Symposium On Recent Advances in Drug Delivery Systems
|
|
|
2005 |
69-70 |
2 |
p. I- 1 p. |
artikel |
216 |
Uterine biology and the intrauterine device
|
Elchalal, U. |
|
1995 |
69-70 |
2 |
p. 151-164 14 p. |
artikel |
217 |
Vaccine delivery to animals
|
Bowersock, Terry L |
|
1999 |
69-70 |
2 |
p. 167-194 28 p. |
artikel |